Nea Management Company, LLC Lumos Pharma, Inc. Transaction History

Nea Management Company, LLC

  • $1.31 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$6.68 - $9.39 $682,923 - $959,977
-102,234 Reduced 61.0%
65,374 $503,000
Q1 2022

May 16, 2022
SELL
$6.58 - $10.09 $1.38 Million - $2.11 Million
-209,308 Reduced 55.53%
167,608 $1.58 Million
Q4 2021

Feb 14, 2022
SELL
$6.84 - $10.04 $1.02 Million - $1.5 Million
-149,747 Reduced 28.43%
376,916 $2.61 Million
Q1 2020

May 06, 2020
BUY
$0.89 - $8.85 $468,730 - $4.66 Million
526,663 New
526,663 $4.48 Million

Others Institutions Holding LUMO

# of Institutions
33
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email